Section of Oncology
Philosophy of Treatment Clinical observation indicates that aggressive behaviour by the melanocyte does not go unchallenged. The wide range in the recorded behaviour of malignant melanoma can be more readily understood if we accept the interplay of varying degrees of malignant propensities of the tumour with varying degrees and modes of the host's defences. It is not unusual to find a state of delicately balanced symbiosis between tumour and host where both survive for many years. On rare occasions it is evident that the host is successful in overcoming the tumour (Everson & Cole 1966) .
Treatment could be realistically aimed firstly at eradicating the disease; secondly controlling the tumour by removing as much tumour as possible, with minimum interference of host defence mechanisms, or perhaps even active boosting of those defence mechanisms; and thirdly it could be aimed at palliation for the effects of uncontrollable tumour. Accurate diagnosis must come before effective and humane treatment.
Good working rules of treatment are a compromise between less extensive surgery for good tumours and singularly ineffective massive resections for bad tumours. With increasing knowledge, we may be able to draw up treatment regimes which are suitably tailored to the prognostic features of any particular tumour. Attention has been drawn (Petersen et al. 1962) to the prognostic significance of host sex and age, tumour site and rate of growth, and also to the remarkably reliable relationship between Lloyd's histological staging and prognosis. This staging can be translated to a clinical level quite accurately and, recently, Clark's classification (Clark et al. 1969) along similar lines has received international recognition.
The undesirable side-effects of treatment on the host must be kept to the minimum consistent with maximum effectiveness in destroying or controlling the tumour. Fine judgement may be necessary in individual cases, where, for instance, the quality of limited life may depend on the degree of disability and disfigurement produced.
Surgical Management Primary tumour: When the primary lesion is all that is detectable at presentation, it is always hoped that the disease is undisseminated and wide local excision, down to the deep fascia but not including it, is advocated (Olsen 1966). The local spread of melanoma is often by dermal lymphatic permeation and 'satellite' metastases are more likely to occur if the primary excision does not extend at least 5 cm from all margins of the tumour.
On the face, such a wide clearance would be mutilating, but fortunately melanoma here seems less aggressive and a margin of from 0.5 to 2.0 cm gives comparable control. On the back, the prognosis is bad and the problem of local recurrence is common; a wider excision with a 10 cm clearance margin gives some reduction in local recurrences, but the prognosis is still bad and even wider clearance does not seem to improve it.
Local secondary tumour: Frequent and thorough follow up is necessary and local recurrences-are then excised with the same urgency and the same margins of excision as for primaries. Repeated local recurrence is worth treating vigorously as it is not necessarily indicative of impending doom.
Regional node secondary tumour: When nodes are palpably affected there is the possibility of undetectable distant spread elsewhere, perhaps lurking in a latent phase under partial natural control.
Metastasizing melanoma can sometimes jump' the regional nodes and it is the practice, at Frenchay Hospital, to remove regional nodes as a block dissection, only when these are judged to be clinically involved with melanoma or when they remain suspiciously so for four weeks. If the nodes are abnormal at presentation of the primary tumour, then the operation is carried out contemporaneously with the wide excision of the primary. Involved nodes and primary tumour are only cleared in continuity when they are adjacent.
The groin dissection is only rarely extended proximal to the inguinal ligament. Such extension of surgery confers no advantage in terms of survival time and it is argued that if the tumour has reached that far then it is highly likely to be out of control and irrevocably disseminated. The only possible reason for super-radical removal of enlarged nodes is to reduce the total tumour mass so that the patient's limited defence mechanisms may have more chance of success. The evidence in favour of elective (prophylactic) en bloc dissection of clinically normal regional nodes is controversial, and many doubts exist as to its value and its advisability (Davis 1972) . It has an appreciable morbidity which also has to be taken into account. Distant secondary tumour: Prognostically ominous but apparently solitary distant metastases, in brain, liver, mesentery or lung, are often worth excising. Surgery can give patients two years or more of useful, enjoyable life.
Surgical Techniques
Valuable refinements of surgical technique have evolved and have been reported recently (Bodenham 1972) .
Conclusions
Most experienced clinicians agree that surgery still plays a dominant role in the treatment of malignant melanoma. Alone, it can rapidly and safely eradicate tumour in 50% of all cases presenting. Surgical repair is generally robust and durable and the discomfort and disfigurement, which may be caused by extensive skin surgery, can be considerably reduced with careful techniques. The late side-effects of surgery are few, controllable and benign.
There is evident surgical inability, however, to eradicate or maintain control over the bad tumours, which is common to all forms of treatment. When surgery fails it is usually a case of the stable door being locked after the horse has bolted; early surgery has an obvious advantage and earlier diagnosis and surgical treatment would be the greatest single advance in melanoma treatment.
It should not be overlooked that there is occasional predeliction of tumour for sites of surgical intervention, such as the skin graft donor site, when the graft is wrongly taken from the same limb as the primary, and the margin of the skin grafted defects which is the commonest site for local recurrence. A transitory immunosuppression follows surgical trauma and anesthesia, and may be a significant but small factor acting for the tumour and against the host.
Whilst stressing the established value of surgery in the treatment of malignant melanoma there are, of course, many fundamental problems still unsolved and the careful evaluation of different means to the same end cannot but be of benefit to our patients ultimately. Moreover it is fairly certain that the breakthrough in cancer therapy will not be surgical.
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